http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
폐색전증에 의한 급성 폐경색으로 발견된 간세포암종 1예
임채준 ( Chae June Lim ),홍지윤 ( Ji Yun Hong ),전충환 ( Chung Hwan Jun ),최성규 ( Sung Kyu Choi ),조성범 ( Sung Bum Cho ) 대한간암학회 2017 대한간암학회지 Vol.17 No.2
Acute pulmonary infarction by tumoral thromboemboli is an extremely rare fatal complication as the first clinical manifestation of hepatocellular carcinoma (HCC) patient with tumoral thrombi in the inferior vena cava. The treatment method has not been established and shown to very poor prognosis despite of trying various modalities such as anticoagulation, radiotherapy and thromboembolectomy. Here, we describe a 74-year-old man who was diagnosed with HCC that presented as pulmonary thromboembolism and subsequent pulmonary infarction as the first manifestation. (J Liver Cancer 2017;17:163-167)
폐전이를 보인 단일결절형 거대 간세포암종 환자에서 순차적인 경동맥화학색전술과 Sorafenib으로 완전관해를 보인 1예
김기현 ( Gi-hyun Kim ),유형민 ( Hyung-min Yu ),임채준 ( Chae-june Lim ),조성범 ( Sung-bum Cho ) 대한간암학회 2016 대한간암학회지 Vol.16 No.1
Current guidelines recommend sorafenib as the first-line molecular target agent for advanced hepatocellular carcinoma (HCC) with extrahepatic metastasis and unresectable HCC. Sorafenib was reported to show survival benefit for patients with advanced HCC. However, complete response is extremely rare in patients treated with sorafenib. Here, we report a 52-year-old man with advanced HCC and pulmonary metastasis who showed complete response by sequential transarterial chemoembolization and continuous sorafenib. Complete response was sustained for 53-month until now. (J Liver Cancer 2016;16:47-51)